Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: The FDA intends to enhance unannounced inspections of foreign facilities that manufacture food and essential medicines for American consumers, which may impact companies like Bristol-Myers Squibb. In the broader market context, Shopify's shares dropped despite exceeding revenue estimates, while AppLovin's shares rose after outperforming expectations and announcing a significant sale.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.